Showing results (71-80 of 125) with videos related to
Sort By:
Pageof 13
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 18, 2021
Real-World Utilization Patterns of Long-Acting Injectable Antipsychotics in Canada: A Retrospective StudyOfer Agid, Gary Remington, Carmen Fung, et al.Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 18, 2015
What does schizophrenia teach us about antipsychotics?Gary Remington, Ofer Agid, George Foussias, et al.JAMA Psychiatry|July 31, 2014
Motivational deficits and cognitive test performance in schizophreniaGagan Fervaha, Konstantine K Zakzanis, George Foussias, et al.Journal of Psychopharmacology (Oxford, England)|January 31, 2025
Challenges for switching central nervous system and psychiatric medication products: A review of the literatureRic M Procyshyn, Martin A Katzman, Howard C Margolese, et al.The Journal of Clinical Psychiatry|April 5, 2011
An algorithm-based approach to first-episode schizophrenia: response rates over 3 prospective antipsychotic trials with a retrospective data analysisOfer Agid, Tamara Arenovich, Gautam Sajeev, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 6, 2018
Does relapse contribute to treatment resistance? Antipsychotic response in first- vs. second-episode schizophreniaHiroyoshi Takeuchi, Cynthia Siu, Gary Remington, et al.Comprehensive Psychiatry|December 16, 2017
Investigating the predictors of happiness, life satisfaction and success in schizophreniaSarah Saperia, Susana Da Silva, Ishraq Siddiqui, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 9, 2015
Antipsychotics and amotivationGagan Fervaha, Hiroyoshi Takeuchi, Jimmy Lee, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 17, 2013
Effect of lurasidone on neurocognitive performance in patients with schizophrenia: a short-term placebo- and active-controlled study followed by a 6-month double-blind extensionPhilip D Harvey, Cynthia O Siu, Jay Hsu, et al.Psychiatry Research|November 10, 2009
Understanding the relationship between baseline BMI and subsequent weight change in antipsychotic trials: effect modification or regression to the mean?David B Allison, Antony D Loebel, Ilise Lombardo, et al.Pageof 13